SCREENING FOR HYPERCOAGULABILITY IN SEPSIS
https://doi.org/10.18705/2311-4495-2016-3-5-34-41
Abstract
Background. Overt disseminated intravascular coagulation (DIC) is independent risk factor in sepsis. Hypercoagulability, present in pre-DIC state, is hardly detected by available screening tests. T hromboelastometry (TEM) and thrombin generation test (TG) showed contradictory results in sepsis.
Objectives. The aim of the study is to compare the screening potential of T EM, TG and local tests to detect hypercoagulability in sepsis.
Design and methods. TEM screening of septic patients revealed hypercoagulability in 21 cases. T G test were performed along with screening coagulation tests and physiological anticoagulants.
Results. There was no thrombin generation in 2 of 21 cases. Increased ETP and Peak revealed only in one case. T he degree of T M-modulated suppression of T G was abnormally low in 15 cases out of 19. Median ETP suppression was only 14% [8,8–24], Peak suppression was 8% [3,4–12,5]. T hus, T EM- identified hypercoagulability was confirmed by both T G and TM+TG tests only in 16 cases (84.2%). Dynamic T EM-criteria (CFT intem) highly correlated with ETP- and PTsuppression values.
Conclusion. Hypercoagulability during sepsis is often due to abnormality in PC pathway. TEM appears to be sensitive POC tool to detect hypercoagulability in sepsis.
About the Authors
V. V. OsovskikhRussian Federation
PhD, head of the group of Anesthesiology and intensive care
Leningradskaya str., 70 Pesochniy pos., Saint Petersburg, Russia, 197758
M. S. Vasilieva
Russian Federation
clinical intern
E. V. Kraisvetnaia
Russian Federation
physician at Anesthesiology and intensive care unit
A. E. Bautin
Russian Federation
PhD, head of the laboratory of Anesthesiology and intensive care
References
1. Aird WC. Sepsis and coagulation. Crit Care Clin. 2005;21:417–431.
2. Levi M, van der Poll T . Inflammation and coagulation. Crit Care Med. 2010; 38: S26–S34.
3. Amaral A, O pal SM, Vincent JL. Coagulation in sepsis. Intensive Care Med. 2004; 30:1032–1040.
4. Taylor Jr. FB, T oh CH, Hoots K, Wada H, Levi M. Towards a definition, clinical and laboratory criteria and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001; 86: 1027–1030.
5. Zeerleder S, Hack CE, Wuillemin WA: Disseminated intravascular coagulation in sepsis. Chest. 2005; 128:2864–2875.
6. Dhainaut JF, Yan SB, Joyce DE et al: T reatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J T hromb Haemost. 2004; 2:1924–1933.
7. Koyama K, Madoiwa S, Nunomiya S: Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study. Critical Care. 2014; 18:R13.
8. Hoppensteadt D, T suruta K, Cunanan J et al: Thrombin Generation Mediators and Markers in Sepsis- Associated Coagulopathy and T heir Modulation by Recombinant T hrombomodulin. T hrombosis/Hemostasis. 2014; 20(2): 129–135.
9. Namestnikov YuA. T hrombin generation test as an integral indicator of the blood clotting system status. Hematology and T ransfusiology = Gematologiya I transfuziologiya. 2010; 55 (2): 32–39. In Russian [Наместников Ю.А. Тест генерации тромбина — интегральный показатель состояния системы свертывания крови. Гематология и трансфузиология. 2010; 55 (2): 32–39].
10. Picoli-Quaino SK, Alves BE, Faiotto VB, Montalvao SA, De Souza CA, Annichino-Bizzacchi JM, De Paula EV. Impairment of thrombin generation in the early phases of the host response of sepsis. J Crit Care. 2014;29(1):31-6.
11. Collins PW. Novel therapies for immune tolerance in haemophilia A. Haemophilia. 2006;12 Suppl 6:94-100; discussion 100-1
12. Dargaud Y, T rzeciak MC, Bordet JС et al. Use of calibrated automated thrombinography +/- thrombomodulin to recognize the prothrombotic phenotype. T hromb. Haemost. 2006; 96(5): 562-567.
13. Brenner T , Schmidt K, Delang M et al. Viscoelastic and aggregometric point-of-care testing in patients with septic shock — cross-links between inflammation and haemostasis. Acta Anaesthesiol Scand. 2012; 56(10): 1277- 1290.
14. Müller MC, Meijers J, Vroom MB et al. Utility of thromboelastography and/or thromboelastometry in adults with sepsis: a systematic review. Critical Care. 2014; 18:R30.
15. Dimitrova-Karamfilova A, Patokova Y, Solarova Tet al. Rotation T hromboelastography for Assessment of Hypercoagulation and T hrombosis in Patients with Cardiovascular Diseases. Journal of Life Sciences. 2012; 6: 28-35.
16. Bolliger D, Seeberger MD, T anaka KA. Principles and Practice of T hromboelastography in Clinical Coagulation Management and T ransfusion Practice. Transfusion Medicine Reviews. 2012; 26(1): 1–13.
17. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013; 39:165–228.
Review
For citations:
Osovskikh V.V., Vasilieva M.S., Kraisvetnaia E.V., Bautin A.E. SCREENING FOR HYPERCOAGULABILITY IN SEPSIS. Translational Medicine. 2016;3(5):34-41. (In Russ.) https://doi.org/10.18705/2311-4495-2016-3-5-34-41